BioSpace News Archive

Business

Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology

Product designed to provide safer, more immediate treatment option for patients

January 9, 2020
·
3 min read
BioMidwest

JOMS study: Jaw surgery improves quality of life in obstructive sleep apnea patients

Surgery that moves the jaws forward can result in significant improvements in long-term quality of life – including functional outcomes and sleep quality – in patients with obstructive sleep apnea, according to a new study.

January 9, 2020
·
3 min read
Deals

Bioniz Therapeutics enters into an option agreement for acquisition by Almirall of its lead clinical candidate BNZ-1 in development for immuno-dermatologic and onco-dermatologic diseases

Bioniz Therapeutics, Inc. announced the execution of an option agreement for acquisition by Almirall including its lead candidate, BNZ-1.

January 9, 2020
·
4 min read
BioCapital

Danaher To Present At The 38th Annual J.P. Morgan Healthcare Conference

Danaher Corporation announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 14, 2020 at 8:00 a.m. PT.

January 9, 2020
·
1 min read
Business

Compugen Highlights Recent Accomplishments and Previews Upcoming Milestones

Encouraging preliminary COM701 Phase 1 clinical data presented at SITC 2019 demonstrated initial signs of anti-tumor activity in highly refractory patient population

January 9, 2020
·
10 min read
Business

Aspen Neuroscience Announces Board of Directors and Scientific Advisory Board

World-renowned leaders will guide Aspen’s efforts to develop the first personalized cell therapy for Parkinson disease

January 9, 2020
·
5 min read
Business

Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer

Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, announced the appointment of Onaiza Cadoret-Manier as chief corporate development and commercial officer reporting to Brett P. Monia, Ph.D., chief executive officer.

January 9, 2020
·
3 min read
Drug Development

New England Journal of Medicine Publishes Results of Pivotal Phase 3 Reblozyl® (luspatercept-aamt) MEDALIST Trial

Data from MEDALIST showed significant clinical benefit of Reblozyl in treating anemia in adults with myelodysplastic syndromes

January 9, 2020
·
16 min read
FDA

Alucent Biomedical Announces FDA Approval to Proceed with Natural Vascular Scaffolding Clinical Trial

Alucent Biomedical Inc. has received U.S. Food and Drug Administration approval to proceed with a Phase 1 clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding technology.

January 9, 2020
·
2 min read
Policy

Newron Announces Initiation of New Clinical Trial With Evenamide in Patients With Schizophrenia, Following Approval of Plan By FDA

Newron Pharmaceuticals S.p.A. announced that it has reached agreement with the U.S. Food and Drug Administration on the design and conduct of explanatory studies with Evenamide required to address previously announced potential safety issues raised by the FDA.

January 9, 2020
·
7 min read